Global Custom Market Research Reports Provider Company


ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America

Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD). It offers engineering techniques and multi-genic gene programs to develop next-generation patient and donor-derived adoptive cellular therapies. Ziopharms pipeline products include Ad-RTS-IL-12 and CAR/Cytokine Products. The companys technology platforms comprise RheoSwitch therapeutic system, UltraVector, adoptive cell therapy, ActoBiotics, AttSite Recombinases and Leap among others. Its products and technologies are used in the treatment of hematologic malignancies, solid tumors and graft-versus-host-disease. Ziopharm is headquartered in Boston, Massachusetts, the US.

ZIOPHARM Oncology Inc Key Recent Developments

Mar 01,2018: Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Feb 12,2018: Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond
Feb 06,2018: Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance
Jan 09,2018: Ziopharm Oncology Provides Update on Standout Technologies During the 36th Annual J.P. Morgan Healthcare Conference
Dec 10,2017: ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting

This comprehensive SWOT profile of ZIOPHARM Oncology Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZIOPHARM Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

ZIOPHARM Oncology Inc - Key Information
ZIOPHARM Oncology Inc - Overview
ZIOPHARM Oncology Inc - Key Employees
ZIOPHARM Oncology Inc - Key Employee Biographies
ZIOPHARM Oncology Inc - Key Operational Heads
ZIOPHARM Oncology Inc - Major Products and Services
ZIOPHARM Oncology Inc - History
ZIOPHARM Oncology Inc - Company Statement
ZIOPHARM Oncology Inc - Locations And Subsidiaries
ZIOPHARM Oncology Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

ZIOPHARM Oncology Inc - Business Description
ZIOPHARM Oncology Inc - Corporate Strategy
ZIOPHARM Oncology Inc - SWOT Analysis
SWOT Analysis - Overview
ZIOPHARM Oncology Inc - Strengths
ZIOPHARM Oncology Inc - Weaknesses
ZIOPHARM Oncology Inc - Opportunities
ZIOPHARM Oncology Inc - Threats
ZIOPHARM Oncology Inc - Key Competitors

Section 3 - Company Financial Performance Charts

ZIOPHARM Oncology Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

ZIOPHARM Oncology Inc, Key Information
ZIOPHARM Oncology Inc, Key Ratios
ZIOPHARM Oncology Inc, Share Data
ZIOPHARM Oncology Inc, Major Products and Services
ZIOPHARM Oncology Inc, History
ZIOPHARM Oncology Inc, Key Employees
ZIOPHARM Oncology Inc, Key Employee Biographies
ZIOPHARM Oncology Inc, Key Operational Heads
ZIOPHARM Oncology Inc, Other Locations
ZIOPHARM Oncology Inc, Subsidiaries
ZIOPHARM Oncology Inc, Key Manufacturing facilities
ZIOPHARM Oncology Inc, Key Competitors
ZIOPHARM Oncology Inc, SWOT Analysis
ZIOPHARM Oncology Inc, Ratios based on current share price
ZIOPHARM Oncology Inc, Annual Ratios
ZIOPHARM Oncology Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

ZIOPHARM Oncology Inc, Performance Chart
ZIOPHARM Oncology Inc, Ratio Charts

BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Keryx Biopharmaceuticals Inc (KERX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Apricus Biosciences Inc (APRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports